INS and diabetes mellitus: Previously, metformin rather sulfonylurea or insulin had been shown benefits in T2DM patients in the United Kingdom Prospective Diabetes Study (UKPDS) in decreased risks of macrovascular complications and all-cause mortality that persisted after trial was over [22, 23].